Products for Research Use Only
RegisterLogin

Epcoritamab

CAT: 0804-HY-P99931-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99931-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Epcoritamab (GEN3013) is an bispecific IgG1 antibody redirecting T-cells toward CD3xCD20+ tumor cells. Epcoritamab induces potent T-cell-mediated cytotoxicity towards B-cell NHL cell lines[1].
CAS Number
2134641-34-0
Product Name Alternative
GEN3013
UNSPSC
12352203
Target
CD20; CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/epcoritamab.html
Purity
99.84
Solubility
10 mM in DMSO
Smiles
[Epcoritamab]
Molecular Weight
(146.28 kDa)
References & Citations
[1]van der Horst HJ, et al. Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment. Blood Cancer J. 2021 Feb 18;11 (2) :38. |[2]Thieblemont C, et al. Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. J Clin Oncol. 2023 Apr 20;41 (12) :2238-2247.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
MBS5819997Epcoritamab
GTR18398646-01Epcoritamab Antibody
CBA1050-01Epcoritamab Biosimilar
E100460Epcoritamab ELISA Kit
MBS1563512-01Research Grade Epcoritamab
E55B1214Epcoritamab (Reference antibody)
KBI1310KRIBIOLISA™ Epcoritamab ELISA
T9901A-086-01Epcoritamab-CD3E Specific Antibody
591837Epcoritamab (CD3E, MS4A1, CD20)
B23149801-01Anti-Human CD3ExCD20 (Epcoritamab)

Popular Products